Exacerbation Reduction and Early and Sustained Improvements in SGRQ, Lung Function, and Symptoms of Nasal Polyposis with Benralizumab for Severe, Eosinophilic Asthma: Phase IIIb ANDHI Trial-MedSci.cn

Exacerbation Reduction and Early and Sustained Improvements in SGRQ, Lung Function, and Symptoms of Nasal Polyposis with Benralizumab for Severe, Eosinophilic Asthma: Phase IIIb ANDHI Trial

Harrison, TW; Chanez, P; Menzella, F; Canonica, GW; Louis, R; Cosio, BG; Lugogo, NL; Mohan, A; Burden, A; McDermott, L; Gil, EG; Zangrilli, JG

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020; 201 ():

科室
- - 订阅+
  - 更多科室
工具
服务